Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of AVAXIM™ 80U-Pediatric Administered Alone or Concomitantly With TRIMOVAX™ in 12-13 Months Old Healthy Hepatitis A Seronegative Turkish Children

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00313950
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:33.583107+00:00
Published At
2014-01-22T00:00:00+00:00
Record Updated At
2014-01-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Measles", "Mumps", "Rubella", "Hepatitis A"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-01-22"
protocolSection.identificationModule.nctId
"NCT00313950"
protocolSection.identificationModule.officialTitle
"Immunogenicity and Safety of AVAXIM\u2122 80U-Pediatric Administered Alone or Concomitantly With TRIMOVAX\u2122 in 12-13 Months Old Healthy Hepatitis A Seronegative Turkish Children"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Measles (protocolSection.conditionsModule.conditions)
  • Mumps (protocolSection.conditionsModule.conditions)
  • Rubella (protocolSection.conditionsModule.conditions)
  • Hepatitis A (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.